Should the buprenorphine dose is insufficient as well as the CYP3A4 inducer can't be reduced or discontinued, changeover the affected individual again to your buprenorphine formulation that permits dose changes. pentobarbital increases toxicity of ifosfamide by influencing hepatic/intestinal